A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes I El-Battrawy, S Albers, L Cyganek, Z Zhao, H Lan, X Li, Q Xu, ... EP Europace 21 (9), 1410-1421, 2019 | 39 | 2019 |
Established and emerging lipid-lowering drugs for primary and secondary cardiovascular prevention DT Michaeli, JC Michaeli, S Albers, T Boch, T Michaeli American Journal of Cardiovascular Drugs 23 (5), 477-495, 2023 | 37 | 2023 |
Studying Brugada syndrome with an SCN1B variants in human-induced pluripotent stem cell-derived cardiomyocytes I El-Battrawy, J Müller, Z Zhao, L Cyganek, R Zhong, F Zhang, ... Frontiers in Cell and Developmental Biology 7, 261, 2019 | 37 | 2019 |
Medical education and mental health during COVID-19: a survey across 9 countries D Michaeli, G Keough, FJ Pérez Domínguez, FA Polanco Ilabaca, ... International Journal of Medical Education, 2022 | 27 | 2022 |
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy DT Michaeli, T Michaeli, S Albers, T Boch, JC Michaeli The European Journal of Health Economics 25 (6), 979-997, 2024 | 25 | 2024 |
Socio-economic burden of disease: Survivorship costs for bladder cancer JC Michaeli, T Boch, S Albers, T Michaeli, DT Michaeli Journal of Cancer Policy 32, 100326, 2022 | 19 | 2022 |
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived … I El‐Battrawy, H Lan, L Cyganek, L Maywald, R Zhong, F Zhang, Q Xu, ... Clinical and Translational Medicine 11 (12), e646, 2021 | 14 | 2021 |
Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations DT Michaeli, T Michaeli, S Albers, JC Michaeli JNCI: Journal of the National Cancer Institute 116 (2), 216-229, 2024 | 11 | 2024 |
A preclinical study on brugada syndrome with a CACNB2 variant using human cardiomyocytes from induced pluripotent stem cells R Zhong, T Schimanski, F Zhang, H Lan, A Hohn, Q Xu, M Huang, Z Liao, ... International Journal of Molecular Sciences 23 (15), 8313, 2022 | 9 | 2022 |
Versorgungsrealität in Deutschland: ein Auszug aus dem Schulterendoprothesenregister der Deutschen Vereinigung für Schulter-und Ellenbogenchirurgie eV (DVSE) J Kircher, B Ohly, S Albers, F Kirchner, R Hudek, P Magosch Obere Extremität 17 (2), 92-98, 2022 | 9 | 2022 |
The healthcare labor shortage: Practice, theory, evidence, and ways forward DT Michaeli, JC Michaeli, S Albers, T Michaeli Theory, Evidence, and Ways Forward (March 26, 2022), 2022 | 6 | 2022 |
Midterm outcomes of autologous bridging of rotator cuff tears with an autologous tendon patch (TEAR patch) S Albers, Y Ono, F Kirchner, MF Fal, J Kircher Journal of Shoulder and Elbow Surgery 33 (2), 312-320, 2024 | 5 | 2024 |
Anterolateral acromioplasty does not change the critical shoulder angle and acromion index in a clinically relevant amount S Thiesemann, F Kirchner, MF Fal, S Albers, J Kircher Arthroscopy: The Journal of Arthroscopic & Related Surgery 38 (11), 2960-2968, 2022 | 5 | 2022 |
Association between clinical trial design characteristics and treatment effect estimates: a meta-analysis of randomized-controlled and single-arm trials supporting the FDA … DT Michaeli, T Michaeli, S Albers, JC Michaeli Available at SSRN 4546126, 2023 | 3 | 2023 |
Patient enrollment per month (accrual) in clinical trials leading to the FDA approval of new cancer drugs DT Michaeli, T Michaeli, S Albers, JC Michaeli Targeted Oncology 19 (5), 797-809, 2024 | 2 | 2024 |
Arthroscopic posterior HAGL repair using a direct transaxillary portal S Albers, MF Fal, J Kircher Arthroscopy Techniques 12 (7), e1027-e1031, 2023 | 2 | 2023 |
The Healthcare Workforce Shortage of Nurses and Physicians: Practice, Theory, Evidence, and Ways Forward DT Michaeli, JC Michaeli, S Albers, T Michaeli Policy, Politics, & Nursing Practice, 15271544241286083, 2024 | 1 | 2024 |
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications DT Michaeli, T Michaeli, S Albers, JC Michaeli BMJ Evidence-Based Medicine, 2024 | 1 | 2024 |
Schulterprothesenimplantation nach Infektion: Was zeigen uns die DVSE Registerdaten? R Hudek, F Kirchner, S Albers, M Farkhondeh Fal, J Kircher Obere Extremität 18 (2), 67-73, 2023 | 1 | 2023 |
How to deal with posterior glenoid erosion in anatomic total shoulder arthroplasty S Albers, R Hudek, J Kircher Obere Extremität 17 (2), 74-83, 2022 | 1 | 2022 |